344 Li et al.
TABLE 1 Data and Elemental Analyses of Compounds 4
Elemental Analysis (Calcd)
H
R1
R2
Yield (%)
mp (◦C)
C
N
4a
4b
4c
4d
4e
4f
H
H
CH3
Ph
H
CH3
Ph
H
98.1
94.3
68.7
63.2
73.5
88.3
80.2
85.6
102–103
167–169
145–146
oil
140–141
165–166
140–141
169–170
50.90 (50.94)
61.20 (61.30)
62.55 (62.50)
63.60 (63.58)
69.08 (69.23)
57.90 (57.83)
58.79 (58.96)
64.75 (64.70)
5.72 (5.66)
5.12 (5.11)
5.54 (5.56)
6.02 (5.96)
5.54 (5.49)
5.06 (4.82)
5.19 (5.20)
4.93 (4.90)
13.20 (13.20)
10.18 (10.22)
10.00 (9.72)
9.20 (9.27)
7.69 (7.69)
8.32 (8.43)
7.90 (8.09)
6.82 (6.86)
PhCH2
PhCH2
PhCH2
CH2O2C6H3CH2
CH2O2C6H3CH2
CH2O2C6H3CH2
4g
4h
CH3
Ph
129–131◦C. 1H NMR (CDCl3): 1.39 (s, 3H, CH3), 2.53
(s, 6H, SCH3), 2.64 (s, 2H, CH2), 2.93 (dd, 2H, J = 6.8,
CH2), 5.91 (s, 2H, CH2), 6.70 (m, 3H).
2.56 (s, 3H, SCH3), 2.90 (s, 2H, CH2), 3.09 (dd, 2H,
J = 8.2, CH2), 5.90 (s, 2H, CH2), 6.65 (m, 3H), 8.38
(bs, 1H, NH).
4g: Following the above method and using 1.83 g
2c and 0.28 g methylhydrazine, 1.38 g 4g was ob-
tained. H NMR (CDCl3): 1.43 (s, 3H, CH3), 2.52 (s,
3-Methylthio-6-methyl-5,6-dihydro-2H-
pyrano[4,3-c]pyrazole-4(2H)-ones 4a–h
1
3H, SCH3), 2.85 (s, 2H, CH2), 2.89 (dd, 2H, J = 8.0,
CH2), 3.72 (s, 3H, NCH3), 5.89 (s, 2H, CH2), 6.63 (m,
3H).
4h: Following the above method and using 1.83 g
2c and 0.65 g phenylhydrazine, 1.73 g 4h was ob-
tained. 1H NMR (CDCl3): 1.46 (s, 3H, CH3), 2.59
(s, 3H, SCH3), 2.88 (s, 2H, CH2), 2.97 (dd, 2H,
J = 8.2, CH2), 5.88 (s, 2H, CH2), 6.61 (m, 3H), 7.45
(m, 5H).
4a: Methylhydrazine (0.28 g, 0.006 mol) was added
dropwise to a mixture of 1.16 g (0.005 mol) 2a in
30 ml ethanol. After agitation for 1 h at room tem-
perature, the solvent was evaporated in vacuum and
gave 1.03 g 4a, which was purified with silicon gel
column using ethyl acetate/petroleum ether (1:2) as
eluent. 1H NMR (CDCl3): 1.49 (d, 3H, J = 6.4, CH3),
2.57 (s, 3H, SCH3), 2.85 (m, 2H, CH2), 3.87 (s, 3H,
NCH3), 4.70 (m, 1H, CH).
4b: Following the above method and using 1.16 g
2a and 0.65 g phenylhydrazine, 1.3 g 4b was ob-
tained. 1H NMR (CDCl3): 1.53 (d, 3H, J = 6.2, CH3),
2.61 (s, 3H, SCH3), 2.97 (m, 2H, CH2), 4.65 (m, 1H),
7.44 (m, 5H).
REFERENCES
[1] Brian, P. W.; Curtis, P. J.; Hemming, H. G.; Unwin, C.
H.; Wright, J. M. Nature 1949, 164, 534.
[2] Knudsen, C. G.; Michaely, W. J.; James, D. R.; Chin,
H. L. M. EP Patent 249812, 1987.
[3] Oishi, H.; Ueda, A.; Tomita, K.; Hosaka, H. JP Patent
2111577, 1989.
[4] Adachi, H.; Aihara, T.; Toshio, T.; Tanaka, K. WO
Patent 01171, 1993.
[5] Thaisrivongs, S.; Yang, C. P.; Strohbach, J. W.; Turner,
S. R. WO Patent 11361, 1994.
[6] Ellsworch, E. L.; Lunney, E.; Tait, B. D. WO Patent
14011, 1995.
[7] Tait, B. D.; Hagen, S.; Domagala, J.; Ellsworth, E.;
Gajda, C.; Hamilton, H.; Vara Prasad, J. V. N.;
Ferguson, D.; Graham, N.; Hupe, D.; Nouhan, C.;
Tummino, P. J.; Humblet, C.; Lunney, E. A.; Pavlovsky,
A.; Rubin, J.; Baldwin, E. T.; Bhat, T. N.; Erickson, J.
W.; Gulnik, S. V.; Liu, B. J Med Chem 1997, 40, 3781.
[8] Wang, Y. M.; Li, Z. M.; Li, J. F.; Li, S. Z.; Zhang, S. H.
Chem J Chinese Univ 1999, 20(5), 1559.
4c: Following the above method and using 1.61 g
2b and 0.3 g 85% hydrazine hydrate solution, 0.97 g
4c was obtained. 1H NMR (CDCl3): 1.48 (s, 3H, CH3),
2.68 (s, 3H, SCH3), 2.94 (s, 2H, CH2), 3.08 (dd, 2H,
J = 7.0, CH2), 7.20 (m, 5H), 8.18 (bs, 1H, NH).
4d: Following the above method and using 1.61 g
2b and 0.28 g methylhydrazine, 0.95 g 4d was ob-
1
tained. H NMR (CDCl3): 1.43 (s, 3H, CH3), 2.62 (s,
3H, SCH3), 2.86 (s, 2H, CH2), 3.02 (dd, 2H, J = 5.6,
CH2), 3.92 (s, 3H, NCH3), 7.24 (m, 5H).
4e: Following the above method and using 1.61 g
2b and 0.65 g phenylhydrazine, 1.32 g 4e was ob-
1
tained. H NMR (CDCl3): 1.46 (s, 3H, CH3), 2.59 (s,
3H, SCH3), 2.95 (s, 2H, CH2), 3.03 (dd, 2H, J = 8.0,
[9] Wang, Y. M.; Li, Z. M.; Han, Y. F. J Appl Chem 2001,
12(6), 475(in Chinese).
[10] Yang, X. P.; Li, Z. M.; Chen, H. S.; Liu, J.; Li, S. Z.
Chem J Chinese Univ 1999, 20, 393.
CH2), 7.16 (m, 5H), 7.45 (m, 5H).
4f: Following the above method and using 1.83 g
2c and 0.3 g 85% hydrazine hydrate solution, 1.46 g
4f was obtained. 1H NMR (CDCl3): 1.51 (s, 3H, CH3),
[11] Wexler, B. A. US Patent 4622062, 1986.